Table 1.
Patient demographics
| Characteristic | Germany | Other countries | Overall comparison P‐value |
|---|---|---|---|
| Patients, n | 93 | 592 | |
| Gender, n (%) | |||
| Female | 58 (62.4) | 343 (57.9) | – |
| Male | 35 (37.6) | 249 (42.1) | |
| HAE diagnosis, n (%) | |||
| HAE type I | 83 (89.2) | 551 (93.1) | – |
| HAE type II | 10 (10.8) | 41 (6.9) | |
| Age at IOS enrolment, years | |||
| n (missing) | 93 (0) | 592 (0) | 0.1076 |
| Median (IQR) | 42.8 (28.7–55.3) | 39.0 (28.4–50.6) | |
| Age at first symptoms, years | |||
| n (missing) | 79 (14) | 508 (84) | 0.5080 |
| Median (IQR) | 11.0 (7.0–19.0) | 12.0 (5.0–18.0) | |
| Age at diagnosis, years | |||
| n (missing) | 89 (4) | 550 (42) | 0.5354 |
| Median (IQR) | 21.9 (11.9–36.2) | 20.8 (13.3–32.8) | |
| Delay in diagnosis, years | |||
| n (missing) | 79 (14) | 497 (95) | 0.3694 |
| Median (IQR) | 4.5 (0.3–15.5) | 7.0 (0.4–17.7) | |
HAE, hereditary angioedema; IOS, Icatibant Outcome Survey; IQR, interquartile range.